Clinical Trials Directory

Trials / Completed

CompletedNCT02752295

Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study intents to determine who will benefit from an intensive brief stress coping intervention week (ISCIW) as secondary prevention for real world affective disorder patients.

Detailed description

Affective disorders are associated with a substantial personal and socio-economic burden. This study evaluates an intensive brief stress-coping intervention week (ISCIW) as feasible follow-up treatment for real world patients who suffer from this highly prevalent and chronic stress-related disorders. Stress-associated blood (Interleukin-6, Homocystein, Myeloperoxidase), saliva cortisol and psychosocial screening parameters will be analyzed to determine who will benefit from the ISCIW. All patients were identified in a preventive medical screening before pre-treatment for at least three month as outpatient and the following inclusion to the follow-up ISCIW-trial at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria. For the three planed groups and interventions see interventions and arms.

Conditions

Interventions

TypeNameDescription
BEHAVIORALstress-coping weekThe multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting.
BEHAVIORALadditional two days follow-up weekendA two-days follow-up which recapitulates previous treatment elements.

Timeline

Start date
2015-05-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-04-26
Last updated
2016-09-16

Source: ClinicalTrials.gov record NCT02752295. Inclusion in this directory is not an endorsement.